play_arrow
Welcome to Online Radio
The Leading Lifestyle Internet Radio
play_arrow
Music 24/7 - Africana
Online Radio
play_arrow
Music 24/7 - International
Online Radio
play_arrow
Music 24/7 - Gospel
Online Radio
play_arrow
Music 24/7 - Latin America
Online Radio
play_arrow
Talk Shows - Stay Updated
Online Radio
play_arrow
Pillars and Plants - Gospel
Online Radio
play_arrow
Audio Stories - A new movie experience
Online Radio
There is no reason to stop using AstraZeneca’s COVID-19 vaccine, the World Health Organisation (WHO) says.
After some recipients of the vaccine reportedly developed blood clots, several European countries including Denmark, Iceland, Norway, Thailand and Bulgaria have suspended administering it.
A 50-year-old man was said to have died in Italy after developing deep vein thrombosis (DVT).
The side effect was said to have started after a certain batch of the vaccine called ABV5300 was administered.
Reacting to the development, a spokesperson of WHO, Margaret Harris said a review of the data on the vaccine proved it has caused no deaths.
She added that WHO’s vaccines advisory committee is currently reviewing the safety data of the vaccine.
“AstraZeneca is an excellent vaccine, as are the other vaccines that are being used,” Harris said.
“We’ve reviewed the data on deaths. There has been no death, to date, proven to have been caused by vaccination.
“Yes, we should continue using the AstraZeneca vaccine.
“We must always ensure that we look for any safety signals when we roll out vaccines, and we must review them.
“But there is no indication to not use it.”
On March 2, Nigeria received its first batch of the AstraZeneca vaccine and has since begun the rollout.
The National Primary Health Care Development Agency (NPHCDA) had said the AstraZeneca vaccine Nigeria got is not part of the batch reported to be causing blood clots.
The Minister of State for Petroleum Resources, Timipre Sylva, says until the conclusion of talks with organised labour, there will be no increment in the pump price of premium motor […]
Post comments (0)